Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Semicarbazide-cadmium_therapy> ?p ?o }
Showing triples 1 to 35 of
35
with 100 triples per page.
- Semicarbazide-cadmium_therapy abstract "Semicarbazide-cadmium therapy was an experimental cancer therapy that was tested in several clinical trials in the Soviet Union during the 1960s. Semicarbazide is an irreversible inhibitor of semicarbazide-sensitive amine oxidase (SSAO), an enzyme possibly involved in exacerbation of inflammation. Cadmium is a heavy metal and can also induce apoptosis.The first study in humans was an open pilot trial conducted in Russia in 1957-1962. It was also patented in Russia. This method was successfully used for treatment of patients in later stages of lung, intestinal, and brest cancer, melanoma, and some other cancer types. The Experiments were accompanied by organizational problems (conflict between soviet authorities and scientists).".
- Semicarbazide-cadmium_therapy wikiPageID "19290856".
- Semicarbazide-cadmium_therapy wikiPageLength "7795".
- Semicarbazide-cadmium_therapy wikiPageOutDegree "19".
- Semicarbazide-cadmium_therapy wikiPageRevisionID "682055881".
- Semicarbazide-cadmium_therapy wikiPageWikiLink Apoptosis.
- Semicarbazide-cadmium_therapy wikiPageWikiLink Cadmium.
- Semicarbazide-cadmium_therapy wikiPageWikiLink Carcinogen.
- Semicarbazide-cadmium_therapy wikiPageWikiLink Category:Cadmium.
- Semicarbazide-cadmium_therapy wikiPageWikiLink Category:Experimental_cancer_treatments.
- Semicarbazide-cadmium_therapy wikiPageWikiLink Category:History_of_medicine.
- Semicarbazide-cadmium_therapy wikiPageWikiLink Category:Semicarbazides.
- Semicarbazide-cadmium_therapy wikiPageWikiLink Hydrazine_sulfate.
- Semicarbazide-cadmium_therapy wikiPageWikiLink Mitogen.
- Semicarbazide-cadmium_therapy wikiPageWikiLink Oxidative_stress.
- Semicarbazide-cadmium_therapy wikiPageWikiLink Primary-amine_oxidase.
- Semicarbazide-cadmium_therapy wikiPageWikiLink Semicarbazide.
- Semicarbazide-cadmium_therapy wikiPageWikiLink Toxic_heavy_metal.
- Semicarbazide-cadmium_therapy wikiPageWikiLinkText "Semicarbazide-cadmium therapy".
- Semicarbazide-cadmium_therapy wikiPageUsesTemplate Template:Reflist.
- Semicarbazide-cadmium_therapy subject Category:Cadmium.
- Semicarbazide-cadmium_therapy subject Category:Experimental_cancer_treatments.
- Semicarbazide-cadmium_therapy subject Category:History_of_medicine.
- Semicarbazide-cadmium_therapy subject Category:Semicarbazides.
- Semicarbazide-cadmium_therapy hypernym Therapy.
- Semicarbazide-cadmium_therapy type Drug.
- Semicarbazide-cadmium_therapy type Field.
- Semicarbazide-cadmium_therapy type Redirect.
- Semicarbazide-cadmium_therapy comment "Semicarbazide-cadmium therapy was an experimental cancer therapy that was tested in several clinical trials in the Soviet Union during the 1960s. Semicarbazide is an irreversible inhibitor of semicarbazide-sensitive amine oxidase (SSAO), an enzyme possibly involved in exacerbation of inflammation. Cadmium is a heavy metal and can also induce apoptosis.The first study in humans was an open pilot trial conducted in Russia in 1957-1962. It was also patented in Russia.".
- Semicarbazide-cadmium_therapy label "Semicarbazide-cadmium therapy".
- Semicarbazide-cadmium_therapy sameAs Q7449365.
- Semicarbazide-cadmium_therapy sameAs m.04lg9jm.
- Semicarbazide-cadmium_therapy sameAs Q7449365.
- Semicarbazide-cadmium_therapy wasDerivedFrom Semicarbazide-cadmium_therapy?oldid=682055881.
- Semicarbazide-cadmium_therapy isPrimaryTopicOf Semicarbazide-cadmium_therapy.